Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
03 2019
Historique:
received: 05 09 2018
accepted: 05 12 2018
pubmed: 22 1 2019
medline: 14 5 2019
entrez: 22 1 2019
Statut: ppublish

Résumé

The molecular alterations that occur in cells before cancer is manifest are largely uncharted. Lung carcinoma in situ (CIS) lesions are the pre-invasive precursor to squamous cell carcinoma. Although microscopically identical, their future is in equipoise, with half progressing to invasive cancer and half regressing or remaining static. The cellular basis of this clinical observation is unknown. Here, we profile the genomic, transcriptomic, and epigenomic landscape of CIS in a unique patient cohort with longitudinally monitored pre-invasive disease. Predictive modeling identifies which lesions will progress with remarkable accuracy. We identify progression-specific methylation changes on a background of widespread heterogeneity, alongside a strong chromosomal instability signature. We observed mutations and copy number changes characteristic of cancer and chart their emergence, offering a window into early carcinogenesis. We anticipate that this new understanding of cancer precursor biology will improve early detection, reduce overtreatment, and foster preventative therapies targeting early clonal events in lung cancer.

Identifiants

pubmed: 30664780
doi: 10.1038/s41591-018-0323-0
pii: 10.1038/s41591-018-0323-0
pmc: PMC7614970
mid: EMS185036
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

517-525

Subventions

Organisme : Wellcome Trust
ID : 211179/Z/18/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 209199/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 211179
Pays : United Kingdom
Organisme : Medical Research Council
ID : G108/596
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

Cancer Sci. 2017 Sep;108(9):1888-1896
pubmed: 28677170
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Curr Protoc Bioinformatics. 2016 Dec 8;56:15.9.1-15.9.17
pubmed: 27930809
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72
pubmed: 12011421
Science. 2015 Sep 25;349(6255):1483-9
pubmed: 26404825
Nat Genet. 2006 Sep;38(9):1043-8
pubmed: 16921376
Cell. 2012 May 25;149(5):994-1007
pubmed: 22608083
Nat Genet. 2014 Feb;46(2):116-25
pubmed: 24413735
Cancer Res. 1997 Jun 15;57(12):2331-5
pubmed: 9192802
Neoplasia. 2004 Sep-Oct;6(5):623-35
pubmed: 15548372
Sci Rep. 2018 Jan 22;8(1):1300
pubmed: 29358629
Cancer Res. 2002 Jul 1;62(13):3636-40
pubmed: 12097266
Nat Rev Cancer. 2004 Mar;4(3):177-83
pubmed: 14993899
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
Curr Protoc Bioinformatics. 2016 Dec 8;56:15.10.1-15.10.18
pubmed: 27930805
Nat Commun. 2016 Jan 29;7:10478
pubmed: 26823093
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
N Engl J Med. 2017 Jun 1;376(22):2109-2121
pubmed: 28445112
PLoS Comput Biol. 2014 Aug 07;10(8):e1003665
pubmed: 25102416
Cancer Treat Rev. 2017 Jul;58:77-90
pubmed: 28704777
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16910-5
pubmed: 20837533
Thorax. 2014 May;69(5):451-7
pubmed: 24227199
Nature. 2011 May 5;473(7345):101-4
pubmed: 21471965
PLoS One. 2014 Mar 20;9(3):e92209
pubmed: 24651729
Genomics. 2016 Dec;108(5-6):185-193
pubmed: 27826049
Oncogene. 2002 Oct 7;21(45):6877-83
pubmed: 12362270
Nat Genet. 2015 Dec;47(12):1402-7
pubmed: 26551669
Histopathology. 2001 Mar;38(3):202-8
pubmed: 11260299
Adv Exp Med Biol. 2016;893:1-19
pubmed: 26667336
BMC Bioinformatics. 2009 May 27;10:161
pubmed: 19473525
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361
pubmed: 27899662
Genome Biol. 2014 Feb 03;15(2):R30
pubmed: 24490765
Behav Brain Res. 2001 Nov 1;125(1-2):279-84
pubmed: 11682119
Thorax. 2007 Jan;62(1):43-50
pubmed: 16825337
Mol Cells. 2015 Sep;38(9):789-95
pubmed: 26242195
Dev Cell. 2018 Mar 26;44(6):679-693.e5
pubmed: 29587142
EMBO Rep. 2012 Jun 01;13(6):528-38
pubmed: 22595889
Genomics. 2011 Oct;98(4):288-95
pubmed: 21839163
Science. 2016 Mar 25;351(6280):1463-9
pubmed: 26940869
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62
pubmed: 26476454
Am J Respir Crit Care Med. 2011 Oct 15;184(8):948-56
pubmed: 21799074
Bioinformatics. 2014 Feb 01;30(3):428-30
pubmed: 24336642
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Curr Protoc Bioinformatics. 2015 Dec 17;52:15.7.1-15.7.12
pubmed: 26678382
Mol Biol Cell. 2002 Jun;13(6):1977-2000
pubmed: 12058064
Cancer Res. 2014 Sep 1;74(17):4853-4863
pubmed: 24970479
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
pubmed: 15761078
Curr Opin Genet Dev. 2014 Feb;24:52-60
pubmed: 24657537
Genome Res. 2009 Sep;19(9):1630-8
pubmed: 19570905
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
Genome Med. 2018 Apr 25;10(1):33
pubmed: 29695279
Bioinformatics. 2009 Nov 1;25(21):2865-71
pubmed: 19561018
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9625-30
pubmed: 15983384
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Lung Cancer. 2002 Oct;38(1):23-9
pubmed: 12367789
Nature. 2012 Sep 27;489(7417):519-25
pubmed: 22960745
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
Eur J Hum Genet. 2015 Sep;23(9):1229-35
pubmed: 25585699
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Epigenetics. 2011 Jun;6(6):692-702
pubmed: 21593595
Thorax. 2014 Jun;69(6):548-57
pubmed: 24550057
Respir Res. 2015 Mar 07;16:33
pubmed: 25848883
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Cancer Res. 1994 Apr 1;54(7):1801-6
pubmed: 8137295
Cell. 2017 Nov 16;171(5):1029-1041.e21
pubmed: 29056346
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16659-64
pubmed: 18946033

Auteurs

Vitor H Teixeira (VH)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Christodoulos P Pipinikas (CP)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Research Department of Cancer Biology and Medical Genomics Laboratory, UCL Cancer Institute, University College London, London, UK.

Adam Pennycuick (A)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Henry Lee-Six (H)

The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.

Deepak Chandrasekharan (D)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Jennifer Beane (J)

Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Tiffany J Morris (TJ)

Research Department of Cancer Biology and Medical Genomics Laboratory, UCL Cancer Institute, University College London, London, UK.

Anna Karpathakis (A)

Research Department of Cancer Biology and Medical Genomics Laboratory, UCL Cancer Institute, University College London, London, UK.

Andrew Feber (A)

Research Department of Cancer Biology and Medical Genomics Laboratory, UCL Cancer Institute, University College London, London, UK.

Charles E Breeze (CE)

Research Department of Cancer Biology and Medical Genomics Laboratory, UCL Cancer Institute, University College London, London, UK.

Paschalis Ntolios (P)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Robert E Hynds (RE)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Mary Falzon (M)

Department of Pathology, University College London Hospitals NHS Trust, London, UK.

Arrigo Capitanio (A)

Department of Pathology, University College London Hospitals NHS Trust, London, UK.

Bernadette Carroll (B)

Department of Thoracic Medicine, University College London Hospital, London, UK.

Pascal F Durrenberger (PF)

Center for Inflammation and Tissue Repair, UCL Respiratory, University College London, London, UK.

Georgia Hardavella (G)

Department of Thoracic Medicine, University College London Hospital, London, UK.

James M Brown (JM)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Andy G Lynch (AG)

Computational Biology and Statistics Laboratory, Cancer Research UK Cambridge Institute, Cambridge, UK.
School of Medicine/School of Mathematics and Statistics, University of St Andrews, St Andrews, UK.

Henry Farmery (H)

Computational Biology and Statistics Laboratory, Cancer Research UK Cambridge Institute, Cambridge, UK.

Dirk S Paul (DS)

Research Department of Cancer Biology and Medical Genomics Laboratory, UCL Cancer Institute, University College London, London, UK.

Rachel C Chambers (RC)

Center for Inflammation and Tissue Repair, UCL Respiratory, University College London, London, UK.

Nicholas McGranahan (N)

CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.

Neal Navani (N)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Department of Thoracic Medicine, University College London Hospital, London, UK.

Ricky M Thakrar (RM)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Department of Thoracic Medicine, University College London Hospital, London, UK.

Charles Swanton (C)

CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Stephan Beck (S)

Research Department of Cancer Biology and Medical Genomics Laboratory, UCL Cancer Institute, University College London, London, UK.

Phillip Jeremy George (PJ)

Department of Thoracic Medicine, University College London Hospital, London, UK.

Avrum Spira (A)

Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Johnson and Johnson Innovation, Cambridge, MA, USA.

Peter J Campbell (PJ)

The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.

Christina Thirlwell (C)

Research Department of Cancer Biology and Medical Genomics Laboratory, UCL Cancer Institute, University College London, London, UK.

Sam M Janes (SM)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK. s.janes@ucl.ac.uk.
Department of Thoracic Medicine, University College London Hospital, London, UK. s.janes@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH